ACR | acute cellular rejection | |
AHRQ | Agency for Healthcare Research and Quality | |
ALK | anaplastic lymphoma kinase | |
ASCO | American Society of Clinical Oncology | |
BCBS | Blue Cross Blue Shield | |
CAD | coronary artery disease | |
CAP | College of American Pathologists | |
CARGO | Cardiac Allograft Rejection Gene Expression Observational | |
CDC | Centers for Disease Control and Prevention | |
CI | confidence interval | |
CLIA | Clinical Laboratory Improvement Amendments of 1988 | |
CMF | cyclophosphamide, methotrexate, and fluorouracil | |
CMS | Centers for Medicare & Medicaid Services | |
CMV | cytomegalovirus | |
COI | conflict of interest | |
CONSORT | Consolidated Standards of Reporting Trials | |
CPRC | Cancer Center Protocol Review Committee | |
CTAF | California Technology Assessment Forum | |
CTMS | clinical trial management systems | |
CTSA | Clinical Translational Science Award | |
dbGaP | database of Genotypes and Phenotypes | |
DNA | deoxyribonucleic acid |
DOD | Department of Defense | |
DSMB | data safety monitoring board | |
EGAPP | Evaluation of Genomic Applications in Practice and Prevention | |
EMB | endomyocardial biopsy | |
EQUATOR | Enhancing the QUAlity and Transparency Of health Research | |
FDA | Food and Drug Administration | |
FFATA | Federal Funding Accountability and Transparency Act | |
FFPE | formalin-fixed, paraffin-embedded | |
FISH | fluorescence in situ hybridization | |
HER2 | human epidermal growth factor receptor 2 | |
HHS | U.S. Department of Health and Human Services | |
HPV | human papillomavirus | |
HR | hazard ratio | |
ICMJE | International Committee of Medical Journal Editors | |
IDE | investigational device exemption | |
IDMC | independent data monitoring committee | |
IHC | immunohistochemistry | |
IMAGE | Invasive Monitoring Attenuation through Gene Expression | |
IND | investigational new drug | |
IOM | Institute of Medicine | |
IOTF | Interagency Oncology Task Force | |
IRB | Institutional Review Board | |
ISHLT | International Society for Heart and Lung Transplantation | |
ISO | International Organization for Standardization | |
IVD | in vitro diagnostic | |
IVDMIA | in vitro diagnostic multivariate index assay | |
LDT | laboratory-developed test | |
LMS | Lung Metagene Score | |
MALDI | matrix-assisted laser desorption/ionization | |
MALDI-TOF | time-of-flight mass spectrometer | |
MF | methotrexate and fluorouracil | |
MIAME | Minimum Information About a Microarray Experiment | |
MIBBI | Minimum Information for Biological and Biomedical Investigations |
MINDACT | Microarray In Node negative and 1-3 positive lymph node Disease may Avoid ChemoTherapy | |
miRNA | micro RNA | |
MoS | Manual of Style: A Guide for Authors and Editors | |
MRI | magnetic resonance imaging | |
mRNA | messenger RNA | |
MS | mass spectrometry | |
NAS | National Academy of Sciences | |
NCCN | National Comprehensive Cancer Network | |
NCI | National Cancer Institute | |
ncRNA | non-coding RNA | |
NIH | National Institutes of Health | |
NIST | National Institute of Standards and Technology | |
NMR | nuclear magnetic resonance | |
NOCEDP | National Ovarian Cancer Early Detection Program | |
NRC | National Research Council | |
NSABP | National Surgical Adjuvant Breast and Bowel Project | |
OHRP | Office of Human Research Protections | |
ORI | Office of Research Integrity | |
PBMC | peripheral blood mononuclear cells | |
PHS | Public Health Service | |
PI | principal investigator | |
PMA | premarket approval | |
PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses | |
PSA | prostate-specific antigen | |
QMS | quality management systems | |
qRT-PCR | quantitative reverse-transcriptase polymerase chain reaction | |
RCT | randomized controlled trial | |
REMARK | REporting recommendations for tumor MARKer prognostic studies | |
RNA | ribonucleic acid | |
RNAseq | RNA sequencing | |
rRNA | ribosomal RNA | |
RS | Recurrence Score | |
RT-PCR | reverse-transcriptase polymerase chain reaction | |
RxPONDER | Rx for POsitive NoDe, Endocrine Responsive breast cancer |
SELDI | surface-enhanced laser desorption/ionization | |
SELDI-TOF | SELDI time-of-flight mass spectrometer | |
SERMs | selective estrogen receptor modulators | |
SGO | Society of Gynecologic Oncology | |
SNP | single nucleotide polymorphism | |
SOP | standard operating procedure | |
SPCI | Simone Protective Cancer Institute | |
SQUIRE | Standards for QUality Improvement Reporting Excellenc | |
SRM | selected reaction monitoring | |
SS | similarity score | |
STARD | STAndards for the Reporting of Diagnostic accuracy studies | |
STROBE | STrengthening the Reporting of OBservational studies in Epidemiology | |
TAILORx | Trial Assigning IndividuaLized Options for Treatment | |
TEC | Blue Cross Blue Shield Technology Evaluation Center | |
TMQF | Translational Medicine Quality Framework | |
tRNA | transfer RNA | |
USPSTF | U.S. Preventive Services Task Force |